Aim: To construct the prokaryotic expression vector pET-21a(+)-hcTnI and prepare the rabbit anti-hcTnI antibody using hcTnI expressed in E.coli as immunogen.
Methods: The full-length gene encoding human cardiac troponin I (hcTnI) was synthesized chemically and inserted into expression plasmid pET-21a(+) to construct recombinant plasmid pET-21a(+)-hcTnI. The recombinant plasmid was transformed into E.coli BL21 (DE3) plysS which then expressed hcTnI under IPTG induction. The immunological activity of the expressed hcTnI was analyzed by Western blot. A rabbit was immunized with purified hcTnI to prepare anti-hcTnI antibody and the Ab's properties were identified.
Results: Human cTnI gene was synthesized and confirmed by DNA sequencing. Positive recombinant clones were identified by restriction enzyme digestion analysis and DNA sequencing. After induction with IPTG, hcTnI with M(r) being 24 000 was expressed in E.coli BL21 (DE3) plysS, and the expressed hcTnI accounted for 28% of total bacterial protein. Western blot analysis showed that the hcTnI protein could be recognized by an anti-hcTnI antibody. Rabbit polyclonal antibody with a good specificity was obtained. The titer of the polyclonal antibody was 3x10(-4).
Conclusion: The recombinant expression plasmid of hcTnI was constructed successfully and expressed in E.coli. The prepared rabbit anti-hcTnI antibody had a high titer and specificity.
Download full-text PDF |
Source |
---|
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
July 2005
Department of Medical Laboratory Sciences, Guangzhou Medical College, Guangzhou 510182, China.
Aim: To construct the prokaryotic expression vector pET-21a(+)-hcTnI and prepare the rabbit anti-hcTnI antibody using hcTnI expressed in E.coli as immunogen.
Methods: The full-length gene encoding human cardiac troponin I (hcTnI) was synthesized chemically and inserted into expression plasmid pET-21a(+) to construct recombinant plasmid pET-21a(+)-hcTnI.
Clin Chem
March 1998
Centre National de la Recherche Scientifique, UMR 9921, Faculté de Pharmacie, Montpellier, France.
The presence of human cardiac troponin I (hcTnI) in serum is considered to be a highly specific biochemical marker of acute myocardial infarction. To better understand the antigenic properties of hcTnI, a set of 68 overlapping peptides covering the complete amino acid sequence of hcTnI was prepared and used in epitope mapping experiments. All 16 anti-hcTnI monoclonal antibodies tested were found to recognize a peptide epitope, indicating that recognition by anti-hcTnI monoclonal antibodies was not dependent on the tertiary structure of the protein.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!